I got to say i am quite impressed by this advisory board. Those are some highly decorated professionals that know their stuff.
It goes without mention the time it has taken to commercialise PromarkerD has been disappointing, many here holding for over 5 years but we can see the progress being made. As each advancement is made the valuation increases.
The market potential of PromarkerD has blue sky potential but it will not happen overnight, rollout will be slow and adoption even slower. I was naively optimistic early on thinking this would sky rocket after Janssen partnership, but have now got a more realistic understanding and appreciation of just how much time and effort it takes to bring new medical technology into the market.
Patience got me a 4x paper gain when I started buying many years ago and I believe believe even more patience will deliver the same. Especially if Endo turns out to be a winner.
Great to see PIQ in the green while everything else in Biotech has been absolute smashed.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)